检索历史清除

首页> Clinical cancer research: an official journal of the American Association for Cancer Research> Erlotinib, gefitinib, and vandetanib inhibit human nucleoside transporters and protect cancer cells from gemcitabine cytotoxicity

Erlotinib, gefitinib, and vandetanib inhibit human nucleoside transporters and protect cancer cells from gemcitabine cytotoxicity

导出原文传递

翻译打印收藏纠错

作者： Damaraju,V.L. ^[1] ; Scriver,T. ^[2] ; Mowles,D. ^[3] ; Kuzma,M. ; Ryan,A.J. ; Cass,C.E. ; Sawyer,M.B.

作者单位： Department of Oncology, University of Alberta, Canada ^[1] Department of Oncology, University of Alberta, Canada, Department of Medical Oncology, Cross Cancer ^[2] Department of Oncology, University of Oxford, Oxford, United Kingdom ^[3]

发布时间 2014-04-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交